Does the addition of clomiphene citrate or letrazole to gonadotropin treatment enhance the oocyte yield in poor responders undergoing IVF?
- 12 October 2011
- journal article
- assisted reproduction-technologies
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 28 (11) , 1067-1072
Abstract
Purpose To evaluate the effect of adjunctive letrazole or clomiphene in IVF stimulation protocols. Methods A retrospective analysis of high dose GnRH antagonist IVF cycles (450–600 IU of gonadotropins) that have met poor responder criteria. Selected consecutive cycles in same patients differed solely in presence or absence of adjunctive clomiphene or letrazole. Results Supplementation with clomiphene citrate in poor responders showed significant improvements (p < 0.05) in estradiol levels (1506 vs. 1044 pg/ml), number of dominant follicles (5.6 vs. 3.9), oocytes retrieved (5.2 vs. 3.4) and number of transferred embryos (1.7 vs. 1.1). It significantly improved biochemical pregnancy rates (18.1% vs. 5.9%) while reducing cycle cancellations (11.7% vs. 32.6%). Letrozole supplementation showed similar effects. Conclusion Both Clomiphene and Letrazole performed similarly and showed significant effects. However, despite increasing oocyte yield and embryo transfer rates, the overall clinical and live birth rate in this population remained low and showed no measurable increase.Keywords
This publication has 21 references indexed in Scilit:
- Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocolFertility and Sterility, 2009
- Letrozole in combination with gonadotropins improves implantation rates, ongoing pregnancy rates and decreases cancellation rates in poor respondersFertility and Sterility, 2008
- Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?Fertility and Sterility, 2008
- What should be the maximum FSH dose in IVF/ICSI in poor responders?Journal of Obstetrics and Gynaecology, 2007
- Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulationFertility and Sterility, 2005
- The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot studyFertility and Sterility, 2005
- GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trialHuman Reproduction, 2005
- A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary reportHuman Reproduction, 2004
- A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 yearsFertility and Sterility, 2004
- Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cyclesHuman Reproduction, 2003